Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB/AKT/PTEN/MAPK pathways
2017 ◽
Vol 94
◽
pp. 1094-1100
◽
Keyword(s):
2010 ◽
Vol 19
(6)
◽
pp. 1537-1541
◽
2011 ◽
Vol 286
(18)
◽
pp. 16082-16090
◽
Keyword(s):
2013 ◽
Vol 65
(7)
◽
pp. 1045-1058
◽
2011 ◽
Vol 416
(3-4)
◽
pp. 246-251
◽
Keyword(s):
2005 ◽
Vol 280
(29)
◽
pp. 27383-27392
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 293
(21)
◽
pp. 8242-8254
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 36
(4)
◽
pp. 938-955
◽
Keyword(s):